SRES 732
A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 12:23 PM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This Senate resolution expresses the sense of the Senate that the FDA’s decisions regarding mifepristone, a medication used for abortion, should be respected based on over 25 years of scientific evidence demonstrating its safety and effectiveness. The resolution calls for equitable, transparent, and evidence-based policies governing access to this medication, particularly in light of recent legal challenges and restrictions on abortion access. It emphasizes the importance of preserving access to medication abortion, especially for marginalized communities.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.